Attached files
| file | filename |
|---|---|
| S-1 - FORM S-1 - Regulus Therapeutics Inc. | d553765ds1.htm |
| EX-1.1 - EX-1.1 - Regulus Therapeutics Inc. | d553765dex11.htm |
| EX-10.48 - EX-10.48 - Regulus Therapeutics Inc. | d553765dex1048.htm |
| EX-10.50 - EX-10.50 - Regulus Therapeutics Inc. | d553765dex1050.htm |
| EX-10.46 - EX-10.46 - Regulus Therapeutics Inc. | d553765dex1046.htm |
| EX-10.47 - EX-10.47 - Regulus Therapeutics Inc. | d553765dex1047.htm |
| EX-10.49 - EX-10.49 - Regulus Therapeutics Inc. | d553765dex1049.htm |
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption “Experts” in this Registration Statement (Form S-1) and related Prospectus of Regulus Therapeutics Inc. and to the incorporation by reference therein of our report dated February 19, 2013, with respect to the financial statements of Regulus Therapeutics Inc., included in its Annual Report (Form 10-K) for the year ended December 31, 2012, filed with the Securities and Exchange Commission.
/s/ Ernst & Young LLP
San Diego, California
June 25, 2013